65 /100
HIGH RISK
Score updated May 30, 2026

SUNE — SUNation Energy Inc. Dilution Risk Tracker

Track SUNE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SUNE — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
95
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
60%
💰 Capital Raise 73%
• Critical: only 2.7 months cash remaining
• Active ATM program with $4M remaining capacity
📉 Score Deterioration 50%
• Score rose 45 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔄 Reverse Split 45%
• 50-day avg $1.65 approaching $1 threshold
• Only 3 months cash — financial pressure
🔔 Track SUNE — Get forecast alerts →

💹 Market Data

Market Cap$5.61M
Shares Outstanding4.12M
Float3.44M
Cash$1.69M
Debt$9.36M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 176.7K shares
#1 Vanguard Group Inc 63.3K shares
#2 Citadel Advisors Llc 43.5K shares
#3 Geode Capital Management, LLC 28.2K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest208.7K
Days to Cover1.0
% of Float6.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
8-K 8K EVENT Apr 15, 2026
424B5 ATM Apr 09, 2026
8-K 8K EVENT Apr 09, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track SUNE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SUNE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for SUNE
📊 SUNE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SUNE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.